Search research articles
Contact Us
Filters
Showing results (31-40 of 98) with videos related to
Page
of 10
Sort By:
Journal of Hepatology
|
July 22, 2018
Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer
Cun Wang, Haojie Jin, Dongmei Gao, et al.
Cell Research
|
March 7, 2018
A CRISPR screen identifies CDK7 as a therapeutic target in hepatocellular carcinoma
Cun Wang, Haojie Jin, Dongmei Gao, et al.
Cancer Research
|
November 18, 2008
Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235
Pieter J A Eichhorn, Magüi Gili, Maurizio Scaltriti, et al.
Molecular and Cellular Biology
|
June 19, 2013
The corepressor CTBP2 is a coactivator of retinoic acid receptor/retinoid X receptor in retinoic acid signaling
Prashanth Kumar Bajpe, Guus J J E Heynen, Lorenza Mittempergher, et al.
European Journal of Immunology
|
October 18, 2019
High-throughput compound screen reveals mTOR inhibitors as potential therapeutics to reduce (auto)antibody production by human plasma cells
Paul Tuijnenburg, Daan J Aan de Kerk, Machiel H Jansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2009
Candidate biomarkers of response to an experimental cancer drug identified through a large-scale RNA interference genetic screen
Jasper Mullenders, Wolfgang von der Saal, Miranda M W van Dongen, et al.
Life Science Alliance
|
August 22, 2020
The RECQL helicase prevents replication fork collapse during replication stress
Bente Benedict, Marit Ae van Bueren, Frank Pa van Gemert, et al.
Genome Medicine
|
November 29, 2018
A role for the unfolded protein response stress sensor ERN1 in regulating the response to MEK inhibitors in KRAS mutant colon cancers
Tonći Šuštić, Sake van Wageningen, Evert Bosdriesz, et al.
Nucleic Acids Research
|
July 2, 2024
Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing
Ruben Schep, Max Trauernicht, Xabier Vergara, et al.
Genome Medicine
|
February 11, 2021
Correction to: A role for the unfolded protein response stress sensor ERN1 in regulating the response to MEK inhibitors in KRAS mutant colon cancers
Tonći Šuštić, Sake van Wageningen, Evert Bosdriesz, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 98) with videos related to
Sort By:
Page
of 10
Journal of Hepatology
|
July 22, 2018
Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer
Cun Wang, Haojie Jin, Dongmei Gao, et al.
Cell Research
|
March 7, 2018
A CRISPR screen identifies CDK7 as a therapeutic target in hepatocellular carcinoma
Cun Wang, Haojie Jin, Dongmei Gao, et al.
Cancer Research
|
November 18, 2008
Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235
Pieter J A Eichhorn, Magüi Gili, Maurizio Scaltriti, et al.
Molecular and Cellular Biology
|
June 19, 2013
The corepressor CTBP2 is a coactivator of retinoic acid receptor/retinoid X receptor in retinoic acid signaling
Prashanth Kumar Bajpe, Guus J J E Heynen, Lorenza Mittempergher, et al.
European Journal of Immunology
|
October 18, 2019
High-throughput compound screen reveals mTOR inhibitors as potential therapeutics to reduce (auto)antibody production by human plasma cells
Paul Tuijnenburg, Daan J Aan de Kerk, Machiel H Jansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2009
Candidate biomarkers of response to an experimental cancer drug identified through a large-scale RNA interference genetic screen
Jasper Mullenders, Wolfgang von der Saal, Miranda M W van Dongen, et al.
Life Science Alliance
|
August 22, 2020
The RECQL helicase prevents replication fork collapse during replication stress
Bente Benedict, Marit Ae van Bueren, Frank Pa van Gemert, et al.
Genome Medicine
|
November 29, 2018
A role for the unfolded protein response stress sensor ERN1 in regulating the response to MEK inhibitors in KRAS mutant colon cancers
Tonći Šuštić, Sake van Wageningen, Evert Bosdriesz, et al.
Nucleic Acids Research
|
July 2, 2024
Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing
Ruben Schep, Max Trauernicht, Xabier Vergara, et al.
Genome Medicine
|
February 11, 2021
Correction to: A role for the unfolded protein response stress sensor ERN1 in regulating the response to MEK inhibitors in KRAS mutant colon cancers
Tonći Šuštić, Sake van Wageningen, Evert Bosdriesz, et al.
Page
of 10